While many companies have spent the years since the COVID-19 pandemic began just hoping to get back on track with the way things were before, Abbott has devised its own definition of the “new normal.” ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
July 17 (Reuters) - Abbott (ABT.N), opens new tab warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, ...
Abbott stock jumped Wednesday despite a mixed first-quarter report thanks to light sales of its Covid tests. Sales at Abbott Laboratories' other segments, though, "were modestly better than the ...
The U.S. Food and Drug Administration has issued an emergency use authorization for a new novel coronavirus test from Abbott Laboratories. Results from the speedy test come back in as little as five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results